Geptanolimab
Product Specifications
CAS Number
2348469-43-0
Target
PD-1/PD-L1
Related Pathways
Apoptosis, Cell Cycle/Checkpoint, Immunology/Inflammation
Purity
0.995
Bioactivity
Geptanolimab (CBT-501) is a humanized IgG4κ monoclonal antibody directed against PD-1 (Programmed Death-1) . Geptanolimab functions by competitively blocking the binding of PD-L1 and PD-L2 to PD-1, thereby reactivating T cell activity. Geptanolimab is under development as an immunotherapeutic agent with potential applications in cancer treatment.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
035025-AP 200 µL
ELAC1, NT (ELAC1, D29, Zinc phosphodiesterase ELAC protein 1, Deleted in Ma29, ElaC homolog protein 1, Ribonuclease Z 1, tRNA 3 endonuclease 1, tRNase Z 1) (AP) discontinued
Sign In for Pricing
View Details 
MBS6357598-01 0.1 mL
TPC6A, NT (TRAPPC6A, Trafficking protein particle complex subunit 6A) (MaxLight 405)
Sign In for Pricing
View Details MBS6357598-02 5x 0.1 mL
TPC6A, NT (TRAPPC6A, Trafficking protein particle complex subunit 6A) (MaxLight 405)
Sign In for Pricing
View Details 
482404 100 µL
GTF2IRD1 (General Transcription Factor II-I Repeat Domain-containing Protein 1, GTF2I Repeat Domain Containing 1)
Sign In for Pricing
View Details